Luxury cocaine rehab — where the treatment is behavioral, because there is no pill.

Cocaine sits in a distinct clinical position. Unlike alcohol and benzodiazepines, cocaine withdrawal is not physically life-threatening — there are no withdrawal seizures or delirium tremens, so a medically managed taper is not required to keep the body safe. And unlike alcohol and opioids, there is no FDA-approved medication to treat the disorder at all. Per the National Institute on Drug Abuse (NIDA), behavioral therapies are the only proven treatment for cocaine use disorder.

This changes what a serious program must be. With alcohol, the headline is medical detox; with cocaine, the headline is the quality of the behavioral treatment and the clinician delivering it. A luxury cocaine program that leans on amenities and a thin therapy schedule is selling the wrong thing entirely. The two real dangers a cocaine program must manage are the cardiovascular risk during use and the depression-and-suicide risk during the crash — alongside a drug supply now widely contaminated with fentanyl.

The most important fact for anyone reading this in distress: cocaine use disorder is treatable, and most people who engage in evidence-based behavioral treatment improve. The absence of a medication does not mean the absence of effective treatment — it means the effective treatment is behavioral, and it is well-validated. Per SAMHSA, structured behavioral therapies produce meaningful, durable reductions in cocaine use.

An estimated 5.5 million Americans used cocaine in the past year and roughly 977,000 had a cocaine use disorder, per NIDA — and most never reach treatment, often because high-functioning users see no external crisis to justify it. The barrier for the executive is rarely the clinical work; it is the operational and reputational cost of stepping away. Peninsula's structure — partial-inpatient options, an undisclosed residence, NDA-bound staff — is built to remove that barrier.

Cocaine's danger is not withdrawal — it is use, and increasingly, contamination. The three risks below are why a serious cocaine program opens with medical screening, even though no detox taper is required.

Cardiovascular emergency

Cocaine is acutely cardiotoxic: it raises the heart's oxygen demand while constricting the vessels that supply it. Per the NIH National Library of Medicine, cardiovascular events such as heart attack, arrhythmia, and stroke are the primary mechanism by which stimulants cause death — even in users without traditional cardiac risk factors. A serious program conducts cardiac screening at intake.

A fentanyl-contaminated supply

Per CDC and NIH data, more than 70% of stimulant-involved overdose deaths in 2022 involved fentanyl — much of it from cocaine unknowingly adulterated with the far more potent opioid. Anyone using cocaine from a non-pharmaceutical source is at overdose risk regardless of intent. Fentanyl test strips and naloxone are harm-reduction basics, and the SAMHSA helpline (1-800-662-HELP) can connect you to local resources.

The crash and suicide risk

The comedown from heavy cocaine use brings depression, exhaustion, and — for some — acute suicidal ideation. This is why, even though cocaine needs no medical detox in the alcohol sense, it warrants medically supported stabilization: monitoring for cardiac issues, screening for fentanyl co-exposure, and clinical attention to mood and safety during the first days.

Cocaine withdrawal is psychological rather than physical, and it follows a recognized course. There is no medical emergency in the alcohol sense — but the crash phase carries genuine depression and suicide risk that warrants clinical monitoring. The phases below describe a typical pattern; timing varies with use history and biology.

It is worth stating plainly, because few programs will: the FDA has approved no medication for cocaine use disorder. Research into repurposed and off-label compounds is active (and a serious program will discuss candidates honestly), but as of 2026 nothing is approved, and any program implying a pharmaceutical fix is misrepresenting the science. What works is behavioral — and the evidence base is strong and specific. These are the named, validated approaches a serious cocaine program is built on.

If a single fact separates a serious cocaine program from a luxury wellness brand, it is whether they run Contingency Management properly.

How Contingency Management works

Per the SAMHSA Treatment Improvement Protocol on stimulant use disorders, CM has the most rigorous empirical support of any psychosocial treatment for stimulant use — and in head-to-head meta-analysis it outperforms treatment as usual and other behavioral approaches. The mechanism is simple: patients earn escalating, tangible rewards for objectively verified abstinence, which restructures the short-term incentive landscape that cocaine hijacks.

Why most programs skip it

It is operationally demanding — frequent objective drug testing, an escalating incentive schedule, and disciplined clinical administration — and historically it sat awkwardly with insurance billing. A serious cocaine program builds CM into the core schedule rather than treating it as an add-on. When you evaluate any cocaine program, ask directly: do you run Contingency Management, how is it structured, and who administers it? A vague answer tells you what you need to know.

For the high-functioning professional, cocaine rarely presents as the cultural stereotype. It presents as performance: the energy to work the second shift after a full day, the confidence to walk into the room, the chemical answer to a workload that has outgrown the hours available. In finance, law, sales, entertainment, and tech, stimulant use is frequently framed internally as a productivity tool rather than a problem — which is exactly why it escalates undetected.

The external markers that usually trigger intervention — job loss, arrest, financial collapse — often never appear, or appear suddenly as a cardiac event or a single catastrophic professional lapse. The high-functioning cocaine user is among the most under-treated precisely because the surface holds so long. Peninsula's model is built for this profile: discreet, clinically deep, and structured so that treatment does not require a public disappearance. See our guide to executive treatment without walking away from your life.

A serious integrative cocaine program in 2026 runs $40,000–$80,000 for 30 days, with most residences in the $55,000–$65,000 range. As with any substance, the cost is driven by clinical staffing — master's-and-above clinicians at a 1:1–1:2 ratio — not amenities. For cocaine specifically, ask what that staffing actually buys: a properly run Contingency Management program and genuine dual-diagnosis capability, not just a comfortable room. See our analysis of private-pay versus premium PPO reimbursement.

What premium PPO plans reimburse

Most serious residences are out-of-network. Premium PPO plans — Aetna POS-PPO, Blue Cross Blue Shield Premier, Cigna Open Access Plus, UnitedHealthcare Choice Plus — typically reimburse out-of-network residential at 20–40% of allowed amounts, recovering $9,000–$18,000 against a 30-day stay.

Parity law and the private-pay option

Under the federal Mental Health Parity and Addiction Equity Act, plans must cover stimulant-use-disorder treatment no more restrictively than comparable medical care. Our insurance guide covers verification; some guests choose private-pay to keep treatment outside the claims record — a legitimate privacy decision for recognizable clients.

Cocaine recovery is built in the months after the residential stay, not during it. Because the treatment is behavioral, continuity matters enormously: the same clinical team carrying CBT, ongoing Contingency Management, and relapse-prevention work through a graduated step-down (residential to intensive outpatient to outpatient) is what holds gains. The levels-of-care overview describes the step-down, and our intensive outpatient program details the continuing structure. For guests with co-occurring conditions, dual-diagnosis care continues through this window.

The first step is a conversation, not a commitment. A twenty-five-minute call with an admissions clinician establishes the cardiac and safety picture, whether co-occurring conditions are present, what level of care fits, and whether Peninsula is the right program — or whether we should recommend somewhere better matched. If you are calling about a loved one, our family guidance helps you prepare. To understand your own use first, the confidential DAST-10 self-assessment is a validated screen and takes two minutes.